Axogen Inc vs GE Aerospace — how do they compare? Axogen Inc trades at $38.69 (market cap $2.06B), while GE Aerospace trades at $360.35 (market cap $369.06B). The key difference: GE Aerospace is far larger — about 179.2× Axogen Inc's market cap, and GE Aerospace pays a 0.53% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | GE | |
|---|---|---|
Market Cap | $2.06B | $369.06B |
Sector | Technology | Industrials |
52-Week High | $46.19 | $378.68 |
52-Week Low | $11.28 | $259.00 |
Enterprise Value | $1.98B | $378.36B |
Dividend Yield | — | 0.53% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
GE trades at $353.42, down 1.63% on the day, with a bullish technical signal supported by moving averages and oversold RSI levels near support at $351. The company has beaten earnings estimates for three consecutive quarters, with Q1 2026 EPS of $1.86 exceeding expectations, while revenue grew to $45.86 billion in 2025. Analyst sentiment is strongly positive with a consensus buy rating and $397 price target, driven by robust aerospace demand and recent defense contract wins.
The outlook remains favorable given strong order growth and strategic investments, but risks include high valuation multiples (P/E of 43.94) and debt levels. Upside is supported by earnings momentum and institutional confidence, though investors should monitor execution on backlog conversion and macroeconomic pressures on the aerospace sector.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →